Mapping pelvic lymph nodes: Guidelines for delineation in intensity-modulated radiotherapy
Tài liệu tham khảo
Kirwan, 2003, A systematic review of acute and late toxicity of concomitant chemoradiation for cervical cancer, Radiother Oncol, 68, 217, 10.1016/S0167-8140(03)00197-X
Creutzberg, 2001, The morbidity of treatment for patients with Stage I endometrial cancer, Int J Radiat Oncol Biol Phys, 51, 1246, 10.1016/S0360-3016(01)01765-5
Perez, 1999, Radiation therapy morbidity in carcinoma of the uterine cervix, Int J Radiat Oncol Biol Phys, 44, 855, 10.1016/S0360-3016(99)00111-X
Bonin, 1996, Bony landmarks are not an adequate substitute for lymphangiography in defining pelvic lymph node location for the treatment of cervical cancer with radiotherapy, Int J Radiat Oncol Biol Phys, 34, 167, 10.1016/0360-3016(95)02055-1
Greer, 1990, Gynecologic radiotherapy fields defined by intraoperative measurements, Gynecol Oncol, 38, 421, 10.1016/0090-8258(90)90084-X
Roeske, 2000, Intensity-modulated whole pelvic radiation therapy in patients with gynecologic malignancies, Int J Radiat Oncol Biol Phys, 48, 1613, 10.1016/S0360-3016(00)00771-9
Nutting, 2000, Reduction of small and large bowel irradiation using an optimized intensity-modulated pelvic radiotherapy technique in patients with prostate cancer, Int J Radiat Oncol Biol Phys, 48, 649, 10.1016/S0360-3016(00)00653-2
Portelance, 2001, Intensity-modulated radiation therapy (IMRT) reduces small bowel, rectum, and bladder doses in patients with cervical cancer receiving pelvic and para-aortic irradiation, Int J Radiat Oncol Biol Phys, 51, 261, 10.1016/S0360-3016(01)01664-9
Mundt, 2002, Intensity-modulated whole pelvic radiotherapy in women with gynecologic malignancies, Int J Radiat Oncol Biol Phys, 52, 1330, 10.1016/S0360-3016(01)02785-7
Mundt, 2003, Preliminary analysis of chronic gastrointestinal toxicity in gynecology patients treated with intensity-modulated whole pelvic radiation therapy, Int J Radiat Oncol Biol Phys, 56, 1354, 10.1016/S0360-3016(03)00325-0
Scheidler, 1997, Radiological evaluation of lymph node metastases in patients with cervical cancer, JAMA, 278, 1096, 10.1001/jama.1997.03550130070040
Williams, 2001, Detection of pelvic lymph node metastases in gynecologic malignancy, AJR Am J Roentgenol, 177, 343, 10.2214/ajr.177.2.1770343
Bipat, 2003, Computed tomography and magnetic resonance imaging in staging of uterine cervical carcinoma, Gynecol Oncol, 91, 59, 10.1016/S0090-8258(03)00409-8
Chao, 2002, Lymphangiogram-assisted lymph node target delineation for patients with gynecologic malignancies, Int J Radiat Oncol Biol Phys, 54, 1147, 10.1016/S0360-3016(02)03040-7
Adli, 2003, Does prone positioning reduce small bowel dose in pelvic radiation with intensity-modulated radiotherapy for gynecologic cancer?, Int J Radiat Oncol Biol Phys, 57, 230, 10.1016/S0360-3016(03)00409-7
Rockall, 2005, Diagnostic performance of nanoparticle-enhanced magnetic resonance imaging in the diagnosis of lymph node metastases in patients with endometrial and cervical cancer, J Clin Oncol, 23, 2813, 10.1200/JCO.2005.07.166
Mack, 2002, Superparamagnetic iron oxide-enhanced MR imaging of head and neck lymph nodes, Radiology, 222, 239, 10.1148/radiol.2221010225
Sigal, 2002, Lymph node metastases from head and neck squamous cell carcinoma, Eur Radiol, 12, 1104, 10.1007/s003300101130
Pannu, 2000, MR imaging of mediastinal lymph nodes, J Magn Reson Imaging, 12, 899, 10.1002/1522-2586(200012)12:6<899::AID-JMRI13>3.0.CO;2-R
Keller, 2004, USPIO-enhanced MRI for preoperative staging of gynecological pelvic tumors, Eur Radiol, 14, 937, 10.1007/s00330-004-2258-8
Koh, 2004, Rectal cancer, Radiology, 231, 91, 10.1148/radiol.2311030142
Hong, 2004, Recurrent squamous cell carcinoma of cervix after definitive radiotherapy, Int J Radiat Oncol Biol Phys, 60, 249, 10.1016/j.ijrobp.2004.02.044
Benedetti-Panici, 1996, Lymphatic spread of cervical cancer, Gynecol Oncol, 62, 19, 10.1006/gyno.1996.0184
Vinnicombe, 1995, Normal pelvic lymph nodes, Radiology, 194, 349, 10.1148/radiology.194.2.7824709
Grubnic, 2002, MR evaluation of normal retroperitoneal and pelvic lymph nodes, Clin Radiol, 57, 193, 10.1053/crad.2001.0893
Sakuragi, 1999, Incidence and distribution pattern of pelvic and paraaortic lymph node metastasis in patients with Stages IB, IIA, and IIB cervical carcinoma treated with radical hysterectomy, Cancer, 85, 1547, 10.1002/(SICI)1097-0142(19990401)85:7<1547::AID-CNCR16>3.0.CO;2-2
Heron, 2003, Conventional 3D conformal versus intensity-modulated radiotherapy for the adjuvant treatment of gynecologic malignancies, Gynecol Oncol, 91, 39, 10.1016/S0090-8258(03)00461-X
McIvor, 1980, Changes in lymph node size induced by lymphography, Clin Radiol, 31, 541, 10.1016/S0009-9260(80)80044-4
Pendlebury, 1993, Role of bipedal lymphangiogram in radiation treatment planning for cervix cancer, Int J Radiat Oncol Biol Phys, 27, 959, 10.1016/0360-3016(93)90474-A
Cherry, 1953, Observations on lymph node involvement in carcinoma of the cervix, J Obstet Gynaecol Br Emp, 60, 368, 10.1111/j.1471-0528.1953.tb14072.x
Henriksen, 1949, The lymphatic spread of carcinoma of the cervix and of the body of the uterus, Am J Obstet Gynecol, 58, 924, 10.1016/0002-9378(49)90200-8